StockData
Journey Medical Corp logo

Journey Medical Corp (DERM) bonds

DERMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3033% below fair value
$3.90+0.20 (+5.41%)

Close on Nov 17, 2026Market cap $110.08MP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Total debt
$25.47M
$5.00M due within a year
Net debt
-$171.00K
After $25.64M of cash
Implied interest rate
14.75%
FY2025 interest ÷ average debt
Interest coverage
-2.2×
FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

Notes and loans outstanding

As tagged in Journey Medical's 10-Q for the period ended Jun 30, 2026

Journey Medical's filings do not break debt down by note

The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySize
Term loan$25.00M

See a number that looks wrong?